Ushbu ish iqtibos qilgan ishlar

171 ta ish

Ish: Exploring cellular immunotherapy platforms in multiple myeloma

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun, Haoyu Sun, Weihua Xiao +2
Sharh maqola20152 iqtibos
ABI
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo +7
Maqola20152 iqtibos
ABI
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun, Haoyu Sun, Cai Zhang +1
Sharh maqola20142 iqtibos
ABI
Are natural killer cells superior CAR drivers?
Hans Klingemann
Maqola20142 iqtibos
ABI
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Sagar Lonial, Jamie Cavenagh
Sharh maqola20092 iqtibos
ABI
Personalized Dendritic Cell-Based Tumor Immunotherapy
Nona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Sharh maqola20092 iqtibos
ABI
Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
Hua Jiang, Wenhao Zhang, Peipei Shang +10
Maqola20132 iqtibos
ABI
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel +1
Sharh maqola20142 iqtibos
ABI
Enhancement of Dendritic Cells as Vaccines for Cancer
Meghan E. Turnis, Cliona M. Rooney
Sharh maqola20102 iqtibos
ABI
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Marina Ratta, Francesco Fagnoni, Antonio Curti +9
Maqola20022 iqtibos
ABI
Regulation of Dendritic Cell Migration to the Draining Lymph Node
Alfonso Martin‐Fontecha, Silvia Sebastiani, Uta E. Höpken +4
Maqola20032 iqtibos
ABI
Targeting B-Cell Maturation Antigen in Multiple Myeloma
Yu‐Tzu Tai, Kenneth C. Anderson
Sharh maqola20152 iqtibos
ABI
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
Kimberly Noonan, Carol Ann Huff, Janice M. Davis +16
Maqola20152 iqtibos
ABI
The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Valentina Hoyos, Ivan Borrello
Sharh maqola20162 iqtibos
ABI
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
Claudia Zelle‐Rieser, Shanmugapriya Thangavadivel, R. Biedermann +5
Maqola20162 iqtibos
ABI
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine, James Miskin, Keith Wonnacott +1
Sharh maqola20172 iqtibos
ABI
A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
Sung‐Hoon Jung, Hyunju Lee, Youn-Kyung Lee +5
Maqola20172 iqtibos
ABI
Immunotherapy for the treatment of multiple myeloma
Sung‐Hoon Jung, Hyunju Lee, Manh-Cuong Vo +2
Sharh maqola20172 iqtibos
ABI
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37
Maqola20172 iqtibos
ABI
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka +14
Maqola20182 iqtibos
ABI
Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu +6
Maqola20182 iqtibos
ABI
Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
Manh-Cuong Vo, Seoyun Yang, Sung‐Hoon Jung +6
Maqola20182 iqtibos
ABI
Cellular immunotherapy in multiple myeloma
Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung +7
Sharh maqola20192 iqtibos
ABI
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions
Bradley D. Hunter, Caron A. Jacobson
Maqola20192 iqtibos
ABI
Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy
Jianming Wu, Hemant Kumar Mishra, Bruce Walcheck
Sharh maqola20192 iqtibos
ABI